Research and development have made a great contribution to medical outcomes, however, this is a major factor in driving increases in the cost of prescription drugs
The latest data demonstrates differences among countries to negotiate pharmaceutical pricing with other industrialized countries purchasing at discounted rates
Medicare is blocked, by law, on how much they can negotiate the cost of pharmaceuticals in the United States
This law must be taken under review
This restriction does not apply to other countries
It is incumbent upon the medical community to monitor prescription patterns so that pharmaceuticals optimize the benefits to the population without overprescribing

Interested in learning more about Pharmaceuticals? We've selected some representative articles where you can learn more. Click HERE to access them.

Contact us to learn more about the pharmaceutical industry and its costs